WhichDirection

November 26, 2017

Ritxuimab's future in ME/CFS

The main finding of the Norwegian Rituximab trial was negative but Rituximab’s ,may role in ME/CFS may not be at an end.

Print Friendly, PDF & Email

Leave a Reply